ReviewJournal of cancer research and clinical oncology2024
TRF1 and TRF2: pioneering targets in telomere-based cancer therapy.
Anoop Kallingal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it